
Pharmagest Interactive SA
F:PHF

Intrinsic Value
The intrinsic value of one
PHF
stock under the Base Case scenario is
57.58
EUR.
Compared to the current market price of 48.1 EUR,
Pharmagest Interactive SA
is
Undervalued by 16%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Pharmagest Interactive SA
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Pharmagest Interactive SA
Balance Sheet Decomposition
Pharmagest Interactive SA
Current Assets | 122.5m |
Cash & Short-Term Investments | 47.4m |
Receivables | 64.7m |
Other Current Assets | 10.3m |
Non-Current Assets | 275.6m |
Long-Term Investments | 92.2m |
PP&E | 29.9m |
Intangibles | 149.9m |
Other Non-Current Assets | 3.5m |
Free Cash Flow Analysis
Pharmagest Interactive SA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Pharmagest Interactive SA
Revenue
|
216.8m
EUR
|
Cost of Revenue
|
-67.7m
EUR
|
Gross Profit
|
149.1m
EUR
|
Operating Expenses
|
-105.3m
EUR
|
Operating Income
|
43.7m
EUR
|
Other Expenses
|
-7.5m
EUR
|
Net Income
|
36.2m
EUR
|
PHF Profitability Score
Profitability Due Diligence
Pharmagest Interactive SA's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Score
Pharmagest Interactive SA's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
PHF Solvency Score
Solvency Due Diligence
Pharmagest Interactive SA's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Score
Pharmagest Interactive SA's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PHF Price Targets Summary
Pharmagest Interactive SA
Dividends
Current shareholder yield for PHF is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PHF
stock under the Base Case scenario is
57.58
EUR.
Compared to the current market price of 48.1 EUR,
Pharmagest Interactive SA
is
Undervalued by 16%.